Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
AFT Pharmaceuticals Ltd. ( (AU:AFP) ) has shared an announcement.
At the 2025 annual shareholder meeting of AFT Pharmaceuticals Ltd., all proposed resolutions were approved. These included the authorization for directors to set Deloitte’s fees as auditor for 2026, the re-election of Hartley Atkinson as a director, and the election of Allison Yorston as a new director. This outcome reflects strong shareholder support and positions the company for continued stability and strategic governance.
More about AFT Pharmaceuticals Ltd.
AFT Pharmaceuticals Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is known for its innovative approach to healthcare solutions and has a significant presence in the New Zealand and Australian markets.
Average Trading Volume: 2,892
Technical Sentiment Signal: Sell
Current Market Cap: A$260.5M
See more insights into AFP stock on TipRanks’ Stock Analysis page.